Agenda

#istanbul229 stories
#turkiye133 stories
#abd95 stories
#ekim56 stories
#sampiyonlar55 stories
#sampiyonlarligi55 stories
#uefa54 stories
#fenerbahce54 stories

BetaThe web app is in beta — some things may be missing or change.

About Privacy Terms of Use

App Store Google Play

Haberin Explore

Profile

Haberin
Explore
Categories
Settings

About
Privacy
Terms of Use

BetaThe web app is in beta — some things may be missing or change.

Command palette

Haberin
Explore
Categories
Settings
About
Privacy

↑↓ to navigate · Enter to open · Esc to close

Your cookie preferences

We use necessary cookies for your session and preferences. You can optionally allow usage measurement and advertising cookies too. Privacy policy

Cookie preferences

Necessary cookies
Session, security (CSRF), theme and country preference. The site does not work without these.
Always on
Usage measurement
To understand which pages are read and where errors occur. No personal data is collected.
Advertising
Third-party cookies for serving and measuring adverts. When off, no advert script is loaded at all.

#istanbul229 stories
#turkiye133 stories
#abd95 stories
#ekim56 stories
#sampiyonlar55 stories
#sampiyonlarligi55 stories
#uefa54 stories
#fenerbahce54 stories

General

Artı Gerçek24 August 2026

Moderna’nın kanser aşısı hisselerini uçurdu: Ancak uzmanlar temkinli

Moderna’nın kişiye özel mRNA kanser aşısının melanom tedavisinde başarılı sonuçlar vermesi, şirket hisselerini tek seansta yüzde 177 yükseltti. Ancak uzmanlar, sonuçların diğer kanser türlerine genellenip genellenemeyeceği ve tedavinin yüksek maliyeti konusunda soru işaretlerine dikkat çekiyor

Comments

You've reached the end of the feed.

#melanom

Stories on this topic, gathered from every source.